What is a 'Second Request' from the Department of Justice?

A 'Second Request' is a formal request for detailed information and documents issued by the U.S. Department of Justice (DOJ) during its antitrust review of a proposed merger or acquisition. It signifies that the DOJ is moving from an initial review to a more in-depth investigation to assess the potential impact of the transaction on competition.

Does receiving a 'Second Request' mean the CME-CBOT merger will be blocked?

Not necessarily. A 'Second Request' indicates increased scrutiny and a more thorough investigation by the DOJ. While it can lead to delays and potentially require divestitures or other remedies to gain approval, it does not automatically mean the merger will be blocked. Many mergers proceed to completion after a 'Second Request'.

How will this impact CME Group's stock price?

The market may react negatively to increased uncertainty and potential delays in the merger. Investors may become more cautious, leading to a possible dip in stock price as they await further clarity on the antitrust review outcome. Conversely, positive news from the DOJ could lead to a rebound.

What should investors do now?

Investors should closely monitor any further updates from CME Group and the Department of Justice regarding the antitrust review. Staying informed about the timeline and any conditions placed on the merger will be crucial for making investment decisions. It's advisable to consult with a financial advisor for personalized guidance.

CME 8-K SEC Disclosure

Summary

CME Group Inc. (CME) filed a Form 8-K on December 1, 2006, to report a significant development in its proposed merger with CBOT Holdings, Inc. The company announced that it had received a 'Second Request' for additional information from the U.S. Department of Justice regarding the merger. This 'Second Request' is a standard part of the antitrust review process, indicating that the Department of Justice is conducting a more in-depth examination of the proposed transaction's potential impact on competition. This development is crucial for investors as it signals a potential delay or further scrutiny of the merger. While a 'Second Request' does not necessarily mean the merger will be blocked, it prolongs the regulatory approval timeline and introduces uncertainty. Investors should closely monitor any further communications from CME Group and the Department of Justice regarding the antitrust review.

Key Highlights

1CME Group Inc. announced it received a 'Second Request' for additional information from the U.S. Department of Justice.
2The 'Second Request' is related to the proposed merger between CME Group and CBOT Holdings, Inc.
3This is a standard procedural step in the antitrust review process.
4The filing indicates the Department of Justice is conducting a deeper review of the merger's competitive implications.
5The event date of the report is November 30, 2006, and it was filed on December 1, 2006.
6The press release detailing this information is attached as Exhibit 99.1 to the filing.

CME GROUP INC. 8-K Report, Corporate Update (Dec 1, 2006)

Summary

Key Highlights

Frequently Asked Questions